Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hib Vaccine in Healthy Infants in China
NCT00808392Phase 3Completed
- Sponsor
- Novartis
- Start
- Nov 2008
- Primary completion
- Feb 2009
- Modality
- Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of VaxemHIB in Haemophilus influenzae type b infection (Hib), sponsored by Novartis. Started Nov 2008; status: completed.
02
Drugs
VaxemHIB
03
Conditions
Haemophilus influenzae type b infection (Hib)
Beyond the preview
Go deeper on NCT00808392.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00808392.